{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:35:42Z","timestamp":1790937342052,"version":"4.1.0"},"reference-count":212,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.antiviral.2012.09.013","type":"journal-article","created":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T20:21:32Z","timestamp":1348690892000},"page":"391-404","source":"Crossref","is-referenced-by-count":105,"title":["Targeting the host or the virus: Current and novel concepts for antiviral approaches against influenza virus infection"],"prefix":"10.1016","volume":"96","author":[{"given":"Suki Man-Yan","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ling","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2012.09.013_b1070","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/135965350601100804","article-title":"Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds","volume":"11","author":"Abed","year":"2006","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2012.09.013_b1075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1750-2659.2011.00304.x","article-title":"Influenza neuraminidase","volume":"6","author":"Air","year":"2011","journal-title":"Influenza Other Respi. Viruses"},{"key":"10.1016\/j.antiviral.2012.09.013_b1080","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1073\/pnas.0900655106","article-title":"TNF\/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection","volume":"106","author":"Aldridge","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2012.09.013_b1085","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1021\/jm0002679","article-title":"BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design","volume":"43","author":"Babu","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2012.09.013_b1090","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1021\/bi9014488","article-title":"Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus","volume":"48","author":"Balannik","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2012.09.013_b1095","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1128\/JVI.01805-08","article-title":"Novel influenza virus NS1 antagonists block replication and restore innate immune function","volume":"83","author":"Basu","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1100","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1086\/522609","article-title":"DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection","volume":"196","author":"Belser","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1105","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.1187816","article-title":"Permissive secondary mutations enable the evolution of influenza oseltamivir resistance","volume":"328","author":"Bloom","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2012.09.013_b1110","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1021\/bi00063a007","article-title":"Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones","volume":"32","author":"Bodian","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2012.09.013_b1115","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2165\/11537960-000000000-00000","article-title":"Drugs in development for influenza","volume":"70","author":"Boltz","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2012.09.013_b1120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coi.2005.11.007","article-title":"The function of gammadelta T cells in innate immunity","volume":"18","author":"Born","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1125","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1128\/JVI.00140-10","article-title":"Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors","volume":"84","author":"Bottcher-Friebertshauser","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1130","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1128\/JVI.01294-10","article-title":"Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2","volume":"85","author":"Bottcher-Friebertshauser","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1135","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1016\/j.vaccine.2009.03.029","article-title":"MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition","volume":"27","author":"Bottcher","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2012.09.013_b1140","doi-asserted-by":"crossref","first-page":"9896","DOI":"10.1128\/JVI.01118-06","article-title":"Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium","volume":"80","author":"Bottcher","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1145","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1126\/science.1110267","article-title":"Professional antigen-presentation function by human gammadelta T Cells","volume":"309","author":"Brandes","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2012.09.013_b1150","first-page":"L66","article-title":"Ontogeny of cyclooxygenase-1 and cyclooxygenase-2 gene expression in ovine lung","volume":"274","author":"Brannon","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1155","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nature08722","article-title":"Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers","volume":"463","author":"Cady","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.09.013_b1160","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nri797","article-title":"Gammadelta T cells: functional plasticity and heterogeneity","volume":"2","author":"Carding","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1165","doi-asserted-by":"crossref","first-page":"6878","DOI":"10.4049\/jimmunol.175.10.6878","article-title":"Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection","volume":"175","author":"Carey","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1170","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood.V84.7.2068.2068","article-title":"Leukocyte-endothelial adhesion molecules","volume":"84","author":"Carlos","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2012.09.013_b1175","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1128\/JVI.02205-08","article-title":"Proteolytic activation of the 1918 influenza virus hemagglutinin","volume":"83","author":"Chaipan","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1180","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMc0905290","article-title":"Use of ribavirin to treat influenza","volume":"361","author":"Chan-Tack","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2012.09.013_b1185","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.4049\/jimmunol.0903816","article-title":"Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production","volume":"184","author":"Chan","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1190","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1128\/AAC.00389-09","article-title":"DAS181 inhibits H5N1 influenza virus infection of human lung tissues","volume":"53","author":"Chan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b1195","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/nm1201-1306","article-title":"A novel influenza A virus mitochondrial protein that induces cell death","volume":"7","author":"Chen","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2012.09.013_b1200","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3201\/eid1601.091304","article-title":"Oseltamivir- and amantadine-resistant influenza virus A (H1N1)","volume":"16","author":"Cheng","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1205","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0002-9343(01)00870-1","article-title":"Clinically relevant differences between the statins: implications for therapeutic selection","volume":"111","author":"Chong","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.antiviral.2012.09.013_b1210","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4049\/jimmunol.164.3.1364","article-title":"The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses","volume":"164","author":"Clark","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1215","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2012.09.013_b1220","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nsmb.1779","article-title":"Structures of influenza A proteins and insights into antiviral drug targets","volume":"17","author":"Das","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1225","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/med.20153","article-title":"Another ten stories in antiviral drug discovery (part C): \u201cOld\u201d and \u201cnew\u201d antivirals, strategies, and perspectives","volume":"29","author":"De Clercq","year":"2009","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2012.09.013_b1230","doi-asserted-by":"crossref","first-page":"e1001329","DOI":"10.1371\/journal.ppat.1001329","article-title":"Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway","volume":"7","author":"de Vries","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2012.09.013_b1235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.antiviral.2011.03.182","article-title":"In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant","volume":"90","author":"Delogu","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b1240","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/518936","article-title":"Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide","volume":"196","author":"Deyde","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1245","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States","volume":"301","author":"Dharan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2012.09.013_b1250","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nature07745","article-title":"The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit","volume":"458","author":"Dias","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.09.013_b1255","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.08.002","article-title":"Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo","volume":"92","author":"Droebner","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b1260","doi-asserted-by":"crossref","first-page":"e1001022","DOI":"10.1371\/journal.ppat.1001022","article-title":"Oseltamivir-resistant pandemic H1N1\/2009 influenza virus possesses lower transmissibility and fitness in ferrets","volume":"6","author":"Duan","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2012.09.013_b1265","doi-asserted-by":"crossref","first-page":"e1002830","DOI":"10.1371\/journal.ppat.1002830","article-title":"Structural and biochemical basis for development of influenza virus inhibitors targeting the PA endonuclease","volume":"8","author":"Dubois","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2012.09.013_b1270","doi-asserted-by":"crossref","first-page":"e1000362","DOI":"10.1371\/journal.pmed.1000362","article-title":"Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial","volume":"7","author":"Duval","year":"2010","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2012.09.013_b1275","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1462-5822.2006.00713.x","article-title":"Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence","volume":"8","author":"Ehrhardt","year":"2006","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1280","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1743-422X-5-109","article-title":"Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay","volume":"5","author":"Eichelberger","year":"2008","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2012.09.013_b1285","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2012.09.013_b1290","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1128\/AAC.11.6.946","article-title":"Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate","volume":"11","author":"Eriksson","year":"1977","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b1295","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1165\/ajrcmb.18.4.2939","article-title":"Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs","volume":"18","author":"Ermert","year":"1998","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1300","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1258\/jrsm.2010.090441","article-title":"The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis","volume":"103","author":"Eyers","year":"2010","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.antiviral.2012.09.013_b1305","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1083\/jcb.151.5.951","article-title":"Caspases disrupt the nuclear-cytoplasmic barrier","volume":"151","author":"Faleiro","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1310","first-page":"43","article-title":"Seasonal influenza vaccines","volume":"333","author":"Fiore","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1315","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1017\/S0950268810000105","article-title":"An assessment of the effect of statin use on the incidence of acute respiratory infections in England during winters 1998\u20131999 to 2005\u20132006","volume":"138","author":"Fleming","year":"2010","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.antiviral.2012.09.013_b1320","doi-asserted-by":"crossref","first-page":"e9106","DOI":"10.1371\/journal.pone.0009106","article-title":"New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets","volume":"5","author":"Friesen","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.09.013_b1325","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1378\/chest.06-1997","article-title":"Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins","volume":"131","author":"Frost","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.antiviral.2012.09.013_b1330","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.4049\/jimmunol.174.8.5033","article-title":"Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury","volume":"174","author":"Fukunaga","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1335","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b1340","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b1345","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b1350","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.chom.2009.04.006","article-title":"Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I","volume":"5","author":"Gack","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2012.09.013_b1355","doi-asserted-by":"crossref","first-page":"28403","DOI":"10.1074\/jbc.R110.129809","article-title":"Influenza hemagglutinin and neuraminidase membrane glycoproteins","volume":"285","author":"Gamblin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.09.013_b1360","doi-asserted-by":"crossref","first-page":"15366","DOI":"10.1073\/pnas.1107906108","article-title":"Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers","volume":"108","author":"Gerritz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2012.09.013_b1365","doi-asserted-by":"crossref","first-page":"7801","DOI":"10.1128\/JVI.00724-07","article-title":"Peptide-mediated interference with influenza A virus polymerase","volume":"81","author":"Ghanem","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1370","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1375","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.virusres.2004.02.034","article-title":"Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors","volume":"103","author":"Gubareva","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b1380","series-title":"Influenza Virology: Current Topics","first-page":"169","article-title":"The anti-influenza activity of M2 and neuraminidase inhibotors","author":"Gubareva","year":"2006"},{"key":"10.1016\/j.antiviral.2012.09.013_b1385","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1086\/318537","article-title":"Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir","volume":"183","author":"Gubareva","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1390","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3851\/IMP1678","article-title":"Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro","volume":"15","author":"Gubareva","year":"2010","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2012.09.013_b1395","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nsmb.1421","article-title":"The structural basis for cap binding by influenza virus polymerase subunit PB2","volume":"15","author":"Guilligay","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1400","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/v1030335","article-title":"A(H5N1) virus evolution in South East Asia","volume":"1","author":"Gutierrez","year":"2009","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2012.09.013_b1405","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.antiviral.2011.07.006","article-title":"Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses","volume":"91","author":"Haasbach","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b1410","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1099\/vir.0.2008\/004606-0","article-title":"The multifunctional NS1 protein of influenza A viruses","volume":"89","author":"Hale","year":"2008","journal-title":"J. Gen. Virol."},{"issue":"Suppl 1","key":"10.1016\/j.antiviral.2012.09.013_b1415","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/591851","article-title":"Developing new antiviral agents for influenza treatment: what does the future hold?","volume":"48","author":"Hayden","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1420","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nature07120","article-title":"Crystal structure of the polymerase PA(C)\u2013PB1(N) complex from an avian influenza H5N1 virus","volume":"454","author":"He","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.09.013_b1425","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1086\/651170","article-title":"Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infection","volume":"201","author":"Hedlund","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1430","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/cid\/cir001","article-title":"Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States","volume":"52","author":"Hernandez","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1435","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1084\/jem.20080201","article-title":"Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand","volume":"205","author":"Herold","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2012.09.013_b1440","doi-asserted-by":"crossref","first-page":"e29778","DOI":"10.1371\/journal.pone.0029778","article-title":"Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus","volume":"6","author":"Hoopes","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.09.013_b1445","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(11)70318-8","article-title":"Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives","volume":"12","author":"Hurt","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1450","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1128\/JVI.01200-09","article-title":"Zanamivir-resistant influenza viruses with a novel neuraminidase mutation","volume":"83","author":"Hurt","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1455","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/eri.11.112","article-title":"Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza","volume":"9","author":"Ikematsu","year":"2011","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.antiviral.2012.09.013_b1460","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1128\/AAC.01579-07","article-title":"Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice","volume":"52","author":"Ilyushina","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b1465","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/135965350701200302","article-title":"Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice","volume":"12","author":"Ilyushina","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2012.09.013_b1470","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/jir.2010.0063","article-title":"Mechanisms of type III interferon expression","volume":"30","author":"Iversen","year":"2010","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b1475","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bmc.2011.10.026","article-title":"Design, synthesis, and evaluation of novel small molecule inhibitors of the influenza virus protein NS1","volume":"20","author":"Jablonski","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2012.09.013_b1480","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1126\/science.1222213","article-title":"An overlapping protein-coding region in influenza A virus segment 3 modulates the host response","volume":"337","author":"Jagger","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2012.09.013_b1485","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35154","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.09.013_b1490","doi-asserted-by":"crossref","first-page":"11960","DOI":"10.1128\/JVI.01678-06","article-title":"Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells","volume":"80","author":"Jones","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1495","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1359-6101(00)00026-5","article-title":"Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression","volume":"12","author":"Julkunen","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.antiviral.2012.09.013_b1500","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nbt.1638","article-title":"Identification of influenza A nucleoprotein as an antiviral target","volume":"28","author":"Kao","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1505","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1128\/JVI.63.11.4603-4608.1989","article-title":"Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics","volume":"63","author":"Kawaoka","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1510","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1354\/vp.37-5-512","article-title":"Cyclooxygenase-2 expression in inflammatory lung lesions of nonhuman primates","volume":"37","author":"Khan","year":"2000","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1515","unstructured":"Kim, C.U., Lew, W., Williams, M., Zhang, L., Swaminathan, S., Bischofberger, N., Chen, M.S., Mendel, D., Li, W., Tai, L., Escarpe, P., Cundy, K.C., Eisenberg, E.J., Lacy, S., Sidwell, R.W., Stevens, R.C., Laver, G.W., 1996. New potent, orally active neuraminidase inhibitors as anti-influenza agents: in vitro and in vivo activity of GS4071 and analogs. In: 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, DC."},{"key":"10.1016\/j.antiviral.2012.09.013_b1520","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1128\/AAC.05529-11","article-title":"Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation","volume":"55","author":"Kim","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b1525","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1128\/JVI.00047-11","article-title":"Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus","volume":"85","author":"Kiso","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1530","doi-asserted-by":"crossref","first-page":"e1001079","DOI":"10.1371\/journal.ppat.1001079","article-title":"Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses","volume":"6","author":"Kiso","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2012.09.013_b1535","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1073\/pnas.91.15.7355","article-title":"Differential expression and activation of a family of murine peroxisome proliferator-activated receptors","volume":"91","author":"Kliewer","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2012.09.013_b1540","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1086\/648378","article-title":"Pre- and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice. Viable alternative to oseltamivir","volume":"200","author":"Koudstaal","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1545","doi-asserted-by":"crossref","first-page":"e1002831","DOI":"10.1371\/journal.ppat.1002831","article-title":"Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of Influenza pH1N1 (2009) polymerase","volume":"8","author":"Kowalinski","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2012.09.013_b1550","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/ni1012","article-title":"Suppressors of cytokine signaling and immunity","volume":"4","author":"Kubo","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1555","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1128\/AAC.01311-09","article-title":"Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration","volume":"54","author":"Kubo","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b1560","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0166-3542(02)00104-3","article-title":"Effect of interleukin-12 level augmented by Kakkon-to, a herbal medicine, on the early stage of influenza infection in mice","volume":"56","author":"Kurokawa","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b1565","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/AAC.39.10.2204","article-title":"Growth impairment resulting from expression of influenza virus M2 protein in Saccharomyces cerevisiae: identification of a novel inhibitor of influenza virus","volume":"39","author":"Kurtz","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b1570","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2012.09.013_b1575","doi-asserted-by":"crossref","first-page":"e8087","DOI":"10.1371\/journal.pone.0008087","article-title":"Influenza morbidity and mortality in elderly patients receiving statins: a cohort study","volume":"4","author":"Kwong","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.09.013_b1580","doi-asserted-by":"crossref","unstructured":"Lackenby, A., Hungnes, O., Dudman, S.G., Meijer, A., Paget, W.J., Hay, A.J., Zambon, M.C., 2008. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro. Surveill. 13, pii: 8026.","DOI":"10.2807\/ese.13.05.08026-en"},{"key":"10.1016\/j.antiviral.2012.09.013_b1585","series-title":"Influenza Virology: Current Topics","first-page":"65","article-title":"The proton selective ion channels of influenza A and B viruses","author":"Lamb","year":"2006"},{"key":"10.1016\/j.antiviral.2012.09.013_b1590","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/toxsci\/kfr109","article-title":"A safety evaluation of DAS181, a sialidase fusion protein, in rodents","volume":"122","author":"Larson","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.antiviral.2012.09.013_b1595","doi-asserted-by":"crossref","first-page":"e1001005","DOI":"10.1371\/journal.ppat.1001005","article-title":"Quasispecies theory and the behavior of RNA viruses","volume":"6","author":"Lauring","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2012.09.013_b1600","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1086\/590499","article-title":"Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection","volume":"198","author":"Lee","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1605","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.antiviral.2011.07.011","article-title":"Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro","volume":"91","author":"Lee","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b1610","doi-asserted-by":"crossref","first-page":"e14320","DOI":"10.1371\/journal.pone.0014320","article-title":"Iota-carrageenan is a potent inhibitor of influenza A virus infection","volume":"5","author":"Leibbrandt","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.09.013_b1615","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2008.10.009","article-title":"Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol","volume":"81","author":"Leneva","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b1620","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/nsmb.1909","article-title":"The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site","volume":"17","author":"Li","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1625","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1515\/BC.2011.121","article-title":"Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections","volume":"392","author":"Ludwig","year":"2011","journal-title":"Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.09.013_b1630","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1203\/01.pdr.0000200798.79840.3d","article-title":"Inhibition of COX-2 aggravates neutrophil migration and pneumocyte apoptosis in surfactant-depleted rat lungs","volume":"59","author":"Lukkarinen","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b1635","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/AAC.50.4.1470-1479.2006","article-title":"Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection","volume":"50","author":"Malakhov","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b1640","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1128\/JVI.02340-09","article-title":"Inhibition of human natural killer cell activity by influenza virions and hemagglutinin","volume":"84","author":"Mao","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1645","doi-asserted-by":"crossref","first-page":"9215","DOI":"10.1128\/JVI.00805-09","article-title":"Influenza virus directly infects human natural killer cells and induces cell apoptosis","volume":"83","author":"Mao","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1650","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1743-422X-4-134","article-title":"Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf\/MEK\/ERK signal cascade","volume":"4","author":"Marjuki","year":"2007","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2012.09.013_b1655","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1124\/mol.108.048769","article-title":"Local not systemic modulation of dendritic cell S1P receptors in lung blunts virus-specific immune responses to influenza","volume":"74","author":"Marsolais","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1660","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1128\/JVI.78.22.12665-12667.2004","article-title":"Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium","volume":"78","author":"Matrosovich","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1665","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1128\/JVI.01542-10","article-title":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2","volume":"84","author":"Matsuyama","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1670","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1462-5822.2007.00902.x","article-title":"Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity","volume":"9","author":"Mazur","year":"2007","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(00)00103-0","article-title":"Resistance of influenza viruses to neuraminidase inhibitors \u2013 a review","volume":"47","author":"McKimm-Breschkin","year":"2000","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b1680","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/infdis\/jiq067","article-title":"Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets","volume":"203","author":"Memoli","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1685","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.01339-05","article-title":"Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use","volume":"50","author":"Monto","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b1690","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1086\/653621","article-title":"A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo","volume":"202","author":"Moscona","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1695","unstructured":"Moss, R., Steigbigel, R., Wurtman, D., Hansen, C., Tranel, K.C., M., Larson, J., Sanders, R., Hawley, S., Li, T., Fang, F., 2011. A phase 2A dose-ranging clinical trial of DAS181 for treatment of influenza in health dults. In: 51st Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, DC"},{"key":"10.1016\/j.antiviral.2012.09.013_b1700","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1534-5807(03)00190-4","article-title":"Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes","volume":"5","author":"Mould","year":"2003","journal-title":"Dev. Cell"},{"key":"10.1016\/j.antiviral.2012.09.013_b1705","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/rmv.575","article-title":"Host factors for replication and transcription of the influenza virus genome","volume":"18","author":"Nagata","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1710","doi-asserted-by":"crossref","first-page":"e9332","DOI":"10.1371\/journal.pone.0009332","article-title":"Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro","volume":"5","author":"Nguyen","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.09.013_b1715","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nature07225","article-title":"The structural basis for an essential subunit interaction in influenza virus RNA polymerase","volume":"454","author":"Obayashi","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.09.013_b1720","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-kappaB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2012.09.013_b1725","series-title":"Fields Virology","first-page":"1647","article-title":"Orthomyxoviridae: the viruses and their replication","author":"Palese","year":"2007"},{"key":"10.1016\/j.antiviral.2012.09.013_b1730","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virusres.2004.11.006","article-title":"Metabolism and antiviral activity of ribavirin","volume":"107","author":"Parker","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b1735","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nature03988","article-title":"A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma","volume":"437","author":"Pascual","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.09.013_b1740","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2011.05.009","article-title":"Inhibition of influenza virus-induced NF-kappaB and Raf\/MEK\/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo","volume":"92","author":"Pinto","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b1745","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1750","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/35060098","article-title":"Influenza virus propagation is impaired by inhibition of the Raf\/MEK\/ERK signalling cascade","volume":"3","author":"Pleschka","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1755","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1086\/605413","article-title":"Phosphoantigen-expanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses","volume":"200","author":"Qin","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1760","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3851\/IMP1804","article-title":"Neuraminidase of 2007\u20132008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution","volume":"16","author":"Rameix-Welti","year":"2011","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2012.09.013_b1765","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4161\/rna.8.2.14513","article-title":"The influenza virus RNA synthesis machine: advances in its structure and function","volume":"8","author":"Resa-Infante","year":"2011","journal-title":"RNA Biol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1770","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3810\/pgm.2009.05.2014","article-title":"Original research: intravenous ribavirin \u2013 review of the FDA\u2019s emergency investigational new drug database (1997\u20132008) and literature review","volume":"121","author":"Riner","year":"2009","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.antiviral.2012.09.013_b1775","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2400","article-title":"The alliance of sphingosine-1-phosphate and its receptors in immunity","volume":"8","author":"Rivera","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1780","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0042-6822(83)90150-2","article-title":"Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin","volume":"127","author":"Rogers","year":"1983","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.09.013_b1785","doi-asserted-by":"crossref","first-page":"29798","DOI":"10.1074\/jbc.M109.029470","article-title":"Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level","volume":"284","author":"Rossignol","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.09.013_b1790","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/ncomms1114","article-title":"Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase","volume":"1","author":"Rudrawar","year":"2010","journal-title":"Nat Commun"},{"key":"10.1016\/j.antiviral.2012.09.013_b1795","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature05114","article-title":"The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design","volume":"443","author":"Russell","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.09.013_b1800","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.1128\/JVI.01424-10","article-title":"Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models","volume":"84","author":"Seibert","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1805","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.00555-08","article-title":"Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008","volume":"52","author":"Sheu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b1810","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/infdis\/jiq005","article-title":"Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008\u20132010","volume":"203","author":"Sheu","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1815","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00705-007-0974-5","article-title":"Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo","volume":"152","author":"Shi","year":"2007","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1820","doi-asserted-by":"crossref","unstructured":"Shobugawa, Y., Saito, R., Sato, I., Kawashima, T., Dapat, C., Dapat, I.C., Kondo, H., Suzuki, Y., Saito, K., Suzuki, H., in press. Clinical effectiveness of neuraminidase inhibitors-oseltamivir, zanamivir, laninamivir, and peramivir-for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010\u20132011 influenza season in Japan. J. Infect. Chemother.","DOI":"10.1007\/s10156-012-0428-1"},{"key":"10.1016\/j.antiviral.2012.09.013_b1825","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(82)92693-9","article-title":"An influenza epicentre?","volume":"2","author":"Shortridge","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2012.09.013_b1830","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.177.4050.705","article-title":"Broad-spectrum antiviral activity of virazole: 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide","volume":"177","author":"Sidwell","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2012.09.013_b1835","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1016\/j.bmcl.2011.06.033","article-title":"Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT","volume":"21","author":"Sielaff","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2012.09.013_b1840","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1073\/pnas.72.1.93","article-title":"Studies on the primary structure of the influenza virus hemagglutinin","volume":"72","author":"Skehel","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2012.09.013_b1845","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.antiviral.2012.09.013_b1850","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.antiviral.2008.06.003","article-title":"Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N","volume":"80","author":"Smee","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b1855","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/AAC.01012-08","article-title":"Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice","volume":"53","author":"Smee","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b1860","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.00933-09","article-title":"Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice","volume":"54","author":"Smee","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b1865","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature08182","article-title":"Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic","volume":"459","author":"Smith","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.09.013_b1870","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/cis351","article-title":"Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus","volume":"55","author":"Sorbello","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1875","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1086\/606060","article-title":"Salicylates and pandemic influenza mortality, 1918\u20131919 pharmacology, pathology, and historic evidence","volume":"49","author":"Starko","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b1880","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1128\/JVI.02649-08","article-title":"Acquisition of a polybasic hemagglutinin cleavage site by a low-pathogenic avian influenza virus is not sufficient for immediate transformation into a highly pathogenic strain","volume":"83","author":"Stech","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.1999.9716","article-title":"Role of hemagglutinin cleavage for the pathogenicity of influenza virus","volume":"258","author":"Steinhauer","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.09.013_b1890","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1002\/j.1460-2075.1992.tb05305.x","article-title":"Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease","volume":"11","author":"Stieneke-Grober","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2012.09.013_b1895","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0952-7915(96)80131-2","article-title":"Mitogen-activated protein kinase cascades and regulation of gene expression","volume":"8","author":"Su","year":"1996","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1900","doi-asserted-by":"crossref","first-page":"19151","DOI":"10.1073\/pnas.1013592107","article-title":"High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity","volume":"107","author":"Su","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2012.09.013_b1905","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1910","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.4049\/jimmunol.1102243","article-title":"Cutting edge: tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection","volume":"187","author":"Teijaro","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1915","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.09.013_b1920","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1128\/AAC.38.12.2827","article-title":"Inhibition of cap (m7G pppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds","volume":"38","author":"Tomassini","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b1925","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0092-8674(94)90006-X","article-title":"Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor","volume":"79","author":"Tontonoz","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2012.09.013_b1930","doi-asserted-by":"crossref","first-page":"e7838","DOI":"10.1371\/journal.pone.0007838","article-title":"Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein","volume":"4","author":"Triana-Baltzer","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.09.013_b1935","doi-asserted-by":"crossref","first-page":"e7788","DOI":"10.1371\/journal.pone.0007788","article-title":"Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein","volume":"4","author":"Triana-Baltzer","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.09.013_b1940","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jac\/dkq387","article-title":"Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181","volume":"66","author":"Triana-Baltzer","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b1945","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1084\/jem.20110226","article-title":"The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice","volume":"208","author":"Tu","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2012.09.013_b1950","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1128\/JVI.02325-09","article-title":"Novel inhibitors of influenza virus fusion: structure\u2013activity relationship and interaction with the viral hemagglutinin","volume":"84","author":"Vanderlinden","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1955","doi-asserted-by":"crossref","first-page":"e1002249","DOI":"10.1371\/journal.ppat.1002249","article-title":"Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition","volume":"7","author":"Vavricka","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2012.09.013_b1960","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jinf.2011.01.014","article-title":"Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia","volume":"62","author":"Viasus","year":"2011","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2012.09.013_b1965","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2004.11.007","article-title":"Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications","volume":"107","author":"Vignuzzi","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b1970","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10004","article-title":"Long-term evolution and transmission dynamics of swine influenza A virus","volume":"473","author":"Vijaykrishna","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.09.013_b1975","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/363418a0","article-title":"Rational design of potent sialidase-based inhibitors of influenza virus replication","volume":"363","author":"von Itzstein","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.09.013_b1980","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1099\/vir.0.025015-0","article-title":"Novel inhibitor of influenza non-structural protein 1 blocks multi-cycle replication in an RNase L-dependent manner","volume":"92","author":"Walkiewicz","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b1985","doi-asserted-by":"crossref","first-page":"12018","DOI":"10.1073\/pnas.1107024108","article-title":"Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2012.09.013_b1990","doi-asserted-by":"crossref","first-page":"8066","DOI":"10.1021\/ja900063s","article-title":"Discovery of spiro-piperidine inhibitors and their modulation of the dynamics of the M2 proton channel from influenza A virus","volume":"131","author":"Wang","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2012.09.013_b1995","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.sbi.2010.12.002","article-title":"Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus","volume":"21","author":"Wang","year":"2011","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.antiviral.2012.09.013_b2000","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1210724","article-title":"Biochemistry. Catching a moving target","volume":"333","author":"Wang","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2012.09.013_b2005","doi-asserted-by":"crossref","first-page":"11566","DOI":"10.1128\/JVI.74.24.11566-11573.2000","article-title":"Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha\/beta interferon","volume":"74","author":"Wang","year":"2000","journal-title":"J. Virol."},{"issue":"Suppl 1","key":"10.1016\/j.antiviral.2012.09.013_b2010","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dki018","article-title":"Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic","volume":"55","author":"Ward","year":"2005","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"10.1016\/j.antiviral.2012.09.013_b2015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.chom.2010.05.008","article-title":"Cellular networks involved in the influenza virus life cycle","volume":"7","author":"Watanabe","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2012.09.013_b2020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/MMBR.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2012.09.013_b2025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2012.09.013_b2030","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nbt.2214","article-title":"Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing","volume":"30","author":"Whitehead","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2012.09.013_b2035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00430-010-0182-x","article-title":"Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate","volume":"200","author":"Wiesener","year":"2011","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2012.09.013_b2040","first-page":"L294","article-title":"Expression and role of cyclooxygenase isoforms in alveolar and peritoneal macrophages","volume":"268","author":"Wilborn","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.antiviral.2012.09.013_b2045","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1128\/JVI.00826-09","article-title":"A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA","volume":"83","author":"Wise","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b2050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1089\/jir.2009.0066","article-title":"Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences","volume":"29","author":"Wolff","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.antiviral.2012.09.013_b2055","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1128\/JVI.00985-12","article-title":"Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation","volume":"86","author":"Wong","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b2060","doi-asserted-by":"crossref","first-page":"e7517","DOI":"10.1371\/journal.pone.0007517","article-title":"Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication","volume":"4","author":"Wunderlich","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.09.013_b2065","doi-asserted-by":"crossref","first-page":"30931","DOI":"10.1074\/jbc.M403258200","article-title":"NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas\/FasL is crucial for efficient influenza virus propagation","volume":"279","author":"Wurzer","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.09.013_b2070","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/emboj\/cdg279","article-title":"Caspase 3 activation is essential for efficient influenza virus propagation","volume":"22","author":"Wurzer","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2012.09.013_b2075","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/AAC.00333-08","article-title":"CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity","volume":"53","author":"Yamashita","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b2080","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/AAC.49.10.4075-4084.2005","article-title":"Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility","volume":"49","author":"Yen","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b2085","doi-asserted-by":"crossref","first-page":"12418","DOI":"10.1128\/JVI.01067-07","article-title":"Neuraminidase inhibitor-resistant recombinant A\/Vietnam\/1203\/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo","volume":"81","author":"Yen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b2090","doi-asserted-by":"crossref","first-page":"e1000350","DOI":"10.1371\/journal.ppat.1000350","article-title":"Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses","volume":"5","author":"Yoshida","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2012.09.013_b2095","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.23.4.577","article-title":"Reduction in fever and symptoms in young adults with influenza A\/Brazil\/78 H1N1 infection after treatment with aspirin or amantadine","volume":"23","author":"Younkin","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b2100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/cid\/cis352","article-title":"Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdm09 under emergency use authorization, October 2009\u2013June 2010","volume":"55","author":"Yu","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.09.013_b2105","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nature07720","article-title":"Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site","volume":"458","author":"Yuan","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.09.013_b2110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jac\/dkn026","article-title":"Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza","volume":"62","author":"Zhang","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2012.09.013_b2115","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1073\/pnas.0711942105","article-title":"Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A\/H5N1 virus","volume":"105","author":"Zheng","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Pt 1","key":"10.1016\/j.antiviral.2012.09.013_b2120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1099\/0022-1317-65-1-191","article-title":"Suppression of influenza virus replication in infected mice by protease inhibitors","volume":"65","author":"Zhirnov","year":"1984","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.09.013_b2125","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1016\/j.ejmech.2010.08.009","article-title":"Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines","volume":"45","author":"Zoidis","year":"2010","journal-title":"Eur. J. Med. Chem."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421200215X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421200215X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T23:37:37Z","timestamp":1687736257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421200215X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":212,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S016635421200215X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2012.09.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}